Market Summary
USD240.50+6.32
Delayed2.70%
ISRG Alerts
ISRG Stock Price
ISRG RSI Chart
ISRG Valuation
ISRG Price/Sales (Trailing)
ISRG Profitability
ISRG Fundamentals
ISRG Revenue
ISRG Earnings
Price Action
52 Week Range
180.07308.97
(Low)(High)
Last 7 days
1.3%
Last 30 days
-4.5%
Last 90 days
-12.4%
Trailing 12 Months
-13.3%
ISRG Financial Health
ISRG Investor Care
Peers (Alternatives to Intuitive Surgical)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
MDT | 105.5B | 30.8B | -7.09% | -24.59% | 25.94 | 3.43 | -3.19% | -17.38% |
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
| MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
| SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
BLFS | 853.3M | 154.8M | -6.04% | 0.61% | -8.2 | 5.51 | 60.29% | -2309.58% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Financials for Intuitive Surgical
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.7% | 6,222 | 6,118 | 5,964 | 5,906 | 5,710 |
| Gross Profit | 1.2% | 4,196 | 4,146 | 4,065 | 4,066 | 3,959 |
| Operating Expenses | 5.1% | 2,619 | 2,491 | 2,367 | 2,253 | 2,138 |
| S&GA Expenses | 4.0% | 1,740 | 1,673 | 1,600 | 1,532 | 1,467 |
| R&D Expenses | 7.4% | 879 | 818 | 767 | 722 | 671 |
| EBITDA | -3.6% | 1,607 | 1,666 | 1,725 | 2,124 | - |
| EBITDA Margin | -5.2% | 0.26* | 0.27* | 0.34* | 0.36* | - |
| Earnings Before Taxes | -3.6% | 1,607 | 1,666 | 1,725 | 1,844 | 1,890 |
| EBT Margin | -5.2% | 0.26* | 0.27* | 0.34* | 0.31* | - |
| Net Income | -4.0% | 1,322 | 1,378 | 1,435 | 1,644 | 1,705 |
| Net Income Margin | -5.7% | 0.21* | 0.23* | 0.29* | 0.28* | - |
| Free Cahsflow | -8.0% | 1,491 | 1,621 | 1,739 | 1,835 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | -2.2% | 12,974 | 13,261 | 13,705 | 13,678 | 13,555 |
| Current Assets | -0.6% | 6,253 | 6,293 | 6,293 | 5,803 | 5,845 |
| Cash Equivalents | 2.8% | 1,581 | 1,538 | 1,536 | 1,103 | 1,291 |
| Inventory | 6.7% | 893 | 837 | 724 | 653 | 587 |
| Net PPE | 5.8% | 2,374 | 2,244 | 2,109 | 1,968 | 1,876 |
| Goodwill | 0.1% | 349 | 348 | 349 | 343 | 344 |
| Liabilities | 10.4% | 1,861 | 1,687 | 1,623 | 1,522 | 1,604 |
| Current Liabilities | 15.3% | 1,422 | 1,233 | 1,175 | 1,112 | 1,150 |
| Shareholder's Equity | -4.1% | 11,042 | 11,515 | 12,082 | 12,157 | 11,901 |
| Retained Earnings | -12.9% | 3,500 | 4,018 | 4,683 | 4,858 | 4,761 |
| Additional Paid-In Capital | 0.2% | 7,704 | 7,685 | 7,484 | 7,355 | 7,164 |
| Accumulated Depreciation | 27.8% | 1,238 | 969 | - | - | - |
| Shares Outstanding | -0.9% | 350 | 353 | 357 | 359 | 358 |
| Minority Interest | 20.6% | 71.00 | 59.00 | 59.00 | 55.00 | 50.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -8.0% | 1,491 | 1,621 | 1,739 | 1,835 | 2,089 |
| Share Based Compensation | 1.9% | 513 | 503 | 485 | 467 | 449 |
| Cashflow From Investing | 784.4% | 1,371 | 155 | -1,228 | -2,079 | -2,461 |
| Cashflow From Financing | -61.8% | -2,572 | -1,590 | -595 | -54.70 | 43.00 |
| Buy Backs | 62.3% | 2,607 | 1,607 | 607 | 107 | 0.00 |
Risks for ISRG
What is the probability of a big loss on ISRG?
68.5%
Probability that Intuitive Surgical stock will be more than 20% underwater in next one year
36.9%
Probability that Intuitive Surgical stock will be more than 30% underwater in next one year.
16.9%
Probability that Intuitive Surgical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does ISRG drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Intuitive Surgical was unfortunately bought at previous high price.
Drawdowns
Returns for ISRG
Cumulative Returns on ISRG
16.5%
10-Year Cumulative Returns
20.0%
7-Year Cumulative Returns
10.0%
5-Year Cumulative Returns
14.3%
3-Year Cumulative Returns
What are the long-term rolling returns for ISRG?
FIve years rolling returns for Intuitive Surgical.
Annualized Returns
Which funds bought or sold ISRG recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -5.37 | 534,326 | 2,108,330 | 0.06% |
2023-03-10 | BAILLIE GIFFORD & CO | added | 1.66 | 345,654,000 | 1,132,740,000 | 1.18% |
2023-03-10 | Financial Alternatives, Inc | new | - | 315,236 | 315,236 | 0.31% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 18.57 | 31,999,400 | 79,154,400 | 0.09% |
2023-03-10 | MATHER GROUP, LLC. | reduced | -12.91 | 55,335 | 295,335 | 0.01% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 18.33 | 508,674 | 1,234,670 | 0.10% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 10.04 | 1,892,380 | 5,283,380 | 0.33% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 1.32 | 10,519,000 | 34,738,000 | 0.17% |
2023-03-03 | TIAA, FSB | reduced | -3.54 | 174,434 | 651,434 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 2,442,550 | 2,442,550 | 0.03% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
ISRG Alerts
Intuitive Surgical News
Schedule 13G FIlings of Intuitive Surgical
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | price t rowe associates inc /md/ | 5.9% | 20,823,995 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 8.33% | 29,425,186 | SC 13G/A | |
| Feb 03, 2023 | blackrock inc. | 8.0% | 28,447,145 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 6.9% | 24,756,021 | SC 13G/A | |
| Feb 07, 2022 | blackrock inc. | 7.4% | 26,538,660 | SC 13G/A | |
| Feb 16, 2021 | price t rowe associates inc /md/ | 8.1% | 9,599,898 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 7.76% | 9,127,891 | SC 13G/A | |
| Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 7.6% | 8,888,304 | SC 13G/A | |
| Feb 14, 2020 | price t rowe associates inc /md/ | 8.9% | 10,347,449 | SC 13G/A |
ISRG Fair Value
Intuitive Surgical fair value in different scenarios
The table shows the Fair Value estimates for Intuitive Surgical for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 89.83 -62.65% | 115.43 -52.00% | 160.35 -33.33% | 205.33 -14.62% | 234.58 -2.46% |
| Current Inflation | 82.50 -65.70% | 104.30 -56.63% | 141.86 -41.01% | 179.18 -25.50% | 203.67 -15.31% |
| Very High Inflation | 73.50 -69.44% | 90.90 -62.20% | 120.15 -50.04% | 148.97 -38.06% | 168.15 -30.08% |
Historical Intuitive Surgical Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Intuitive Surgical
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 10, 2023 | DEF 14A | DEF 14A | |
| Mar 10, 2023 | DEFA14A | DEFA14A | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for ISRG
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-01 | Curet Myriam | sold | -286,273 | 228 | -1,253 | evp & chief medical officer |
2023-02-28 | Widman Fredrik | sold (taxes) | -104,602 | 229 | -456 | vp corporate controller |
2023-02-28 | Curet Myriam | sold (taxes) | -344,314 | 229 | -1,501 | evp & chief medical officer |
2023-02-28 | GUTHART GARY S | acquired | - | - | 6,371 | president & ceo |
2023-02-28 | DeSantis Robert | acquired | - | - | 3,679 | evp & chief product officer |
2023-02-28 | MOHR MARSHALL | acquired | - | - | 3,259 | executive vp global business s |
2023-02-28 | Samath Jamie | sold (taxes) | -159,655 | 229 | -696 | chief financial officer |
2023-02-28 | Charlton Henry L | sold (taxes) | -170,666 | 229 | -744 | senior vice president & chief |
2023-02-28 | Rosa David J. | acquired | - | - | 3,760 | evp chief strategy & growth of |
2023-02-28 | Samath Jamie | acquired | - | - | 2,009 | chief financial officer |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Income Statement
2022-09-30Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
| Revenue: | ||||
| Total revenue | $ 1,557.4 | $ 1,403.3 | $ 4,567.2 | $ 4,159.4 |
| Cost of revenue: | ||||
| Total cost of revenue | 505.3 | 431.9 | 1,482.1 | 1,261.7 |
| Gross profit | 1,052.1 | 971.4 | 3,085.1 | 2,897.7 |
| Operating expenses: | ||||
| Selling, general and administrative | 436.1 | 363.3 | 1,245.6 | 1,039.5 |
| Research and development | 217.1 | 165.5 | 634.9 | 487.6 |
| Total operating expenses | 653.2 | 528.8 | 1,880.5 | 1,527.1 |
| Income from operations | 398.9 | 442.6 | 1,204.6 | 1,370.6 |
| Interest and other income, net | 3.9 | 18.5 | 7.5 | 65.5 |
| Income before taxes | 402.8 | 461.1 | 1,212.1 | 1,436.1 |
| Income tax expense | 78.1 | 73.9 | 204.4 | 90.7 |
| Net income | 324.7 | 387.2 | 1,007.7 | 1,345.4 |
| Less: net income attributable to noncontrolling interest in joint venture | 0.7 | 6.7 | 10.3 | 21.4 |
| Net income attributable to Intuitive Surgical, Inc. | $ 324.0 | $ 380.5 | $ 997.4 | $ 1,324.0 |
| Net income per share attributable to Intuitive Surgical, Inc.: | ||||
| Basic (in dollars per share) | $ 0.91 | $ 1.07 | $ 2.79 | $ 3.72 |
| Diluted (in dollars per share) | $ 0.90 | $ 1.04 | $ 2.74 | $ 3.63 |
| Shares used in computing net income per share attributable to Intuitive Surgical, Inc.: | ||||
| Basic (in shares) | 355.3 | 356.8 | 357.2 | 355.6 |
| Diluted (in shares) | 360.5 | 366.8 | 363.7 | 365.1 |
| Other comprehensive loss, net of tax: | ||||
| Change in unrealized gains on hedge instruments | $ 2.3 | $ 2.0 | $ 7.7 | $ 8.0 |
| Change in unrealized losses on available-for-sale securities | (37.3) | (4.5) | (161.4) | (20.5) |
| Change in foreign currency translation losses | (10.0) | (2.8) | (12.0) | (7.9) |
| Change in prior service cost for employee benefit plans | 0.1 | 0.2 | 0.2 | 0.4 |
| Other comprehensive loss | (44.9) | (5.1) | (165.5) | (20.0) |
| Total comprehensive income | 279.8 | 382.1 | 842.2 | 1,325.4 |
| Less: comprehensive income (loss) attributable to noncontrolling interest | (0.8) | 6.6 | 8.2 | 21.0 |
| Total comprehensive income attributable to Intuitive Surgical, Inc. | 280.6 | 375.5 | 834.0 | 1,304.4 |
| Corporate Joint Venture | ||||
| Operating expenses: | ||||
| Less: net income attributable to noncontrolling interest in joint venture | 0.7 | 6.7 | 10.3 | 21.4 |
| Product | ||||
| Revenue: | ||||
| Total revenue | 1,297.5 | 1,170.6 | 3,806.3 | 3,481.2 |
| Cost of revenue: | ||||
| Total cost of revenue | 421.6 | 355.8 | 1,239.9 | 1,049.1 |
| Service | ||||
| Revenue: | ||||
| Total revenue | 259.9 | 232.7 | 760.9 | 678.2 |
| Cost of revenue: | ||||
| Total cost of revenue | $ 83.7 | $ 76.1 | $ 242.2 | $ 212.6 |
ISRG Balance Sheet
2022-09-30Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,538.0 | $ 1,290.9 |
| Short-term investments | 2,775.9 | 2,913.1 |
| Accounts receivable, net | 849.6 | 782.7 |
| Inventory | 837.1 | 587.1 |
| Prepaids and other current assets | 292.5 | 271.1 |
| Total current assets | 6,293.1 | 5,844.9 |
| Property, plant, and equipment, net | 2,243.7 | 1,876.4 |
| Long-term investments | 3,078.1 | 4,415.5 |
| Deferred tax assets | 587.4 | 441.4 |
| Intangible and other assets, net | 710.3 | 633.2 |
| Goodwill | 348.2 | 343.6 |
| Total assets | 13,260.8 | 13,555.0 |
| Current liabilities: | ||
| Accounts payable | 164.2 | 121.2 |
| Accrued compensation and employee benefits | 308.2 | 350.1 |
| Deferred revenue | 358.9 | 377.2 |
| Other accrued liabilities | 402.1 | 301.3 |
| Total current liabilities | 1,233.4 | 1,149.8 |
| Other long-term liabilities | 453.4 | 453.7 |
| Total liabilities | 1,686.8 | 1,603.5 |
| Contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2022, and December 31, 2021 | 0.0 | 0.0 |
| Common stock, 600.0 shares authorized, $0.001 par value, 353.3 shares and 357.7 shares issued and outstanding as of September 30, 2022, and December 31, 2021, respectively | 0.4 | 0.4 |
| Additional paid-in capital | 7,684.8 | 7,164.0 |
| Retained earnings | 4,017.8 | 4,760.9 |
| Accumulated other comprehensive loss | (187.6) | (24.2) |
| Total Intuitive Surgical, Inc. stockholders’ equity | 11,515.4 | 11,901.1 |
| Noncontrolling interest in joint venture | 58.6 | 50.4 |
| Total stockholders’ equity | 11,574.0 | 11,951.5 |
| Total liabilities and stockholders’ equity | $ 13,260.8 | $ 13,555.0 |